{"ticker": {"uuid": "620660eb-eb88-4612-9524-928ff241df4b", "symbol": "CRBU", "name": "Caribou Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Caribou Biosciences Inc (CRBU) Institutional Confidence", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE9PQ3NXRHBjLUF4OU9EbDFHMW1KVE1pYy0wS3ZiZjQ2MTgwcHhuM3pZWjVBdk9kamhMeVBNWXVVd0pCMkdQeXRtQWJrYmNOWmpkTkJ1Z2VwZEQ0OU41YTFCU0hwTHRLbjN2WHFTZE1tdTU?oc=5", "source_name": "TradingKey", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Medical Stocks Lagging Caribou Biosciences (CRBU) This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxONXJDUllyVkQ0RlBmRGhJVGtWWl9wbGZvRVhkV2RJbTRBN1l3M2hFNVhyamhhLW9KN1dFX0ktY2JlTzhHS1FOWkp3OUJCVDY2U0VoSU1uTEdlbTZZUnF0WWlsbzRzaUh6RENGMkNwa0dha1JJeENwb0xycEhzdWZ1eDBicDQ2WnBuTVF3ZFIzbnFQZkNGRGpOWElUZFl1RHNRbUc5Vy1R?oc=5", "source_name": "Market source", "published_at": "2026-07-09T13:40:04+00:00", "published_display": "09 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou CEO set for fireside chat at cell therapy conference June 30", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPQ1djN1NnVTkwZUhvSW5rbWhNQkd6ZzQ5VHNvSEwxUDNDZnZZZzhzYXlzYWlhQ1dKWG9WTkpxM1JkVVdFdUE2Q1JTY1ZtbmVGZFFXbnllbjBQUDJpejBRSk1DOExDaHJKdjRwNkh0OWRfdHhyaGktVGNEQjNJTWFXcWw0aGtiaDFQRng5N0piMFBkMlpOZ3l2TGstOEtIU2s2WUhEYVVycDN3OXh5YUk1NGNwYXpId0hCM3FZSzhCMA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-29T12:05:19+00:00", "published_display": "29 Jun 2026 12:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/caribou-biosciences-participate-h-c-120000570.html", "source_name": "GlobeNewswire", "published_at": "2026-06-29T12:00:00+00:00", "published_display": "29 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences (NASDAQ: CRBU) holders reject officer exculpation", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPSUlNdkZ0QjFHQ2F1RDBoak03VlFqVnVTWUdVZkgzNHhaYU5lRks3WnNDUzVVd1k3bGZ5dHA0eHMtb2M0NEFaSUFIb1N0eG5wQXB0dTVGVEZNZUNfdFYtV2hpS3dwdmZ5RnowRnZhX085MENsX3FPWjlpbzJlZEV2eEE5UjYxZy1oSDRrZVQwMmdvMUdRM2M4NlBodTZEVm1xZGx0ckNWalMxNmVXaFFpT3dR?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CRBU News | CARIBOU BIOSCIENCES INC (NASDAQ:CRBU)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE9PODAzUVczQUItUW1RRDBaMGtBeDJIcmFTLVFrSFJNeUZBX2NEZndnSDNLbTVDX3Bidy03ZnJSSVcxWTVRMktCRGlrdGZlWkpLVllSSkM2OGZmQXM?oc=5", "source_name": "ChartMill", "published_at": "2026-06-17T00:00:00+00:00", "published_display": "17 Jun 2026 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQSHBsb1daN1ZUbkdTTF91b0pNVkxpdUVxcXVGWHc4WjVwc3FmWXo3S0haVEp5eUhhd0YyazJ5Mk8xUFJCd0I0cVBKUW4xODlYMnVIUzVmbGdadnZkbVJKLXItM09hbWtGbHhFd0ItQ2JQMHM2elE4TE90NDVPRTR6QW9HMGc3MWkycmo4OUR4cGxxZmNBQ1FTYmlvTHNabmoxSjBRWkFJbDEycnJ6T2c0dU9rWGd0S095b3ZnYW5YVExoZHJfS0pR?oc=5", "source_name": "Investing News Network", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences, Inc. (CRBU) Presents at European Hematology Association (EHA) 2026 Congress - Slideshow", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPemFQMFpDUXJGT3JpS0ZqTXNTMTNwQWlsaUxiZVBXdUtBNERnWTdzLXFkN05BRTVGUFN2STJzclYzd3diYjM0T3ZILWthbE50NFo0LUljQWd1X2NNSENKUU9lZlQyNGQtRVY0NG16YzdGZVFJUnN3NndFeXVEUFFFWEJ3UkNBUmsteHJGR2V5SmQ2YmhJNjF2a053VkMzel9BdURiY2xkRGtzX0hqUU1tWjdwZXZJLUZDTXB2bkY3dVNtRlRXVmVYaXA3RQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences Potential Non-Hodgkin Lymphoma Cell Therapy Shows 'Durable' Responses", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/caribou-biosciences-potential-non-hodgkin-124018133.html", "source_name": "MT Newswires", "published_at": "2026-06-11T12:40:18+00:00", "published_display": "11 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/caribou-biosciences-reports-dose-escalation-120000206.html", "source_name": "GlobeNewswire", "published_at": "2026-06-11T12:00:00+00:00", "published_display": "11 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences (CRBU) reports durable phase 1 CAR-T responses in lymphoma and myeloma", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPM1dlcU1QMVlfOHp1UVpwYzZHM3pna2czRm5LbUUxQnVBTjdOV0hyY19JejRUcnZSTjd5TUp5aWdScWpvQjB5NkJlemIxV21ZTG1pQ2pGWjBhTVcwVFZ5ZDd2RndzOXZrOTJTcjd1YXJUaXJ5VWJ4TjdQTTd0cUtkMmlFMHVXcTl1WVpzMkgxeGUyRHczTjJwNDdmaU9WYVNGbzBBMlBodWpRbTAwNm92MlRB?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences Says CRISPR CAR-T Is Pivotal-Ready, CB-011 Data Nears", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOS1ZtWDdRQmZ3XzJ0MllueHpSTm5GU290ODBHTE90RkxTR0hRLW0tbEFnNWJoTENhQ1g5blhuUV92VWxRWTQ4UHFuV1FST25OSDBBaGhraGZSV1loSDB1QVNjNkZha05QRm9WMG1zNWc0LWJDazBwN05Vb2F5WE8wYlFqTUhaVHBGV1pJbWpMY3IwYTJkUl9JY3BrcVk2OVhGdXhrWHg1Yw?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences (CRBU) Gets A Higher Target As Confidence In Its Pipeline Grows", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOX2NDNnlNT1RPV2gxWGs5X1N3c1pFblI3Y3J4eUEtOWNOdG9TajFwd1p5X2Y0THBzdDRRVkgxdlRvV05SLWZiQjZ3T1FjNXVCTUhCY2x2QjNUSy13QTQ4YU9IMElzNGthb3VJUFBzWERJNmJndU5jazVRYmVaQWVtbjhyS0VNcmxHX1Rta3o3VmZHR0ZjRlFtQlEzTHNpbThyNUhtQ1Q4eEM?oc=5", "source_name": "Market source", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/caribou-biosciences-participate-2026-jefferies-200500567.html", "source_name": "GlobeNewswire", "published_at": "2026-05-27T20:05:00+00:00", "published_display": "27 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou CEO in Jefferies 2026 healthcare fireside chat", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPQnNxTldEdnYwVkNSX2lKV1lFd2E4b2wzOGxPbXNlZmo5bVBRVzRMSnN1bDg4MTdXT0JTaVdLT1IwRmFXSm5qTFdjUURXY1ZBN0hxYUM5VzFYTzB2RG1nT1hrLUNmYlN4X1Q5R0sxRUpiNm9HekR3SzRBaGE5S2VweDh2d1ZmUlVJbVk0eG1pbGw0RU5SQS1EZG4zYUwwZnF3ZXdxUUVwOThvbGdaYTlKaExpWU9IZWVINUE?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference", "summary": "", "url": "https://finance.yahoo.com/news/caribou-biosciences-participate-h-c-200500953.html", "source_name": "GlobeNewswire", "published_at": "2026-05-13T20:05:00+00:00", "published_display": "13 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Need To Know: Analysts Are Much More Bullish On Caribou Biosciences, Inc. (NASDAQ:CRBU) Revenues", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Industry Analysts Just Made A Massive Upgrade To Their Caribou Biosciences, Inc. (NASDAQ:CRBU) Revenue Forecasts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNd3M4WkVVSEV3SDRhVVpxUVUxQ050OEhzQ2pIdHR6a05vVzVFeHRHOFJVVm5PY2tnZUNQN1VnV2hzVUppNnE1ckp2TjZEVXRhblpnTExWdjYtZjZ5ek9MZFlYOVh0SG9QVFNfSDU1bkdwbkpvZ2cxN1c3cGhuR05ZbUx3MmNvZ0JX?oc=5", "source_name": "Market source", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CRISPR biotech Caribou Biosciences plans H.C. Wainwright talk May 19", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQeDRPWkZMQUZ3anRfcUI3VzE5V2tzQkxhejFfVFZWbDlTZ1RiVG44YVdlQmxyZnE5SDJ4a1FhY2Q4amticmVPeHVac183aUF4bEVtMFU2M0tOS0RBRjhtbW40bzlLcm55UUFWdFhLMDNPdEVpN0gxTHVzZklsbjZ3Y1YzSS1HdWdtNEd0Xy12eC1ReVRVaDl0VG5mQ1RreDd0eGItbjBnR2Zad0VBUGphWElJT25vNHNaalViOThITQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNcVYxOUVZcTc5eXpfV05yRG9tdEQ1aktjZ2stNm1QMDNiSnd3Uk52cEQ4QzQxMFdvUGhnRDJEdkVDemdhd0FPdVZ1M1V4WWNKWHU1ZEZRVFlkZXIzRWZ4SUVYM1hJTUZRMU8tSGlESjBpUzdiN09rcEdKMjY0NVZ1VE83NXY1cjdFOUtMVk9VTkZnR1Z5RmVWVUg2TjhXR1NidVJKcGtYUUw?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences to Participate in the BofA Securities 2026 Health Care Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPLVNwUHF0X0Q4cGJzaVp2T1YyV3ZhVl9CN2toeUtnX3BSQjVYdnZOaTItUWVTTFY5Z3BRRk5qMXZweDE5Tjd5OHJnU3lfYUlDZmdPZk1QZUluUnRQQmV3NG04WFFhUEJaNlpCY09ESk16Uy01MmtPLVExdXRRZXFDLWdiWFhYeXliVWd6X3pNaWxNdkR4R2N4S1c4RlV3M0hEUHJJbm9oWHg2TjVzd21zdWhR?oc=5", "source_name": "Investing News Network", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOZEtreE5mUkxCdXhVa3NCVjNfR0xQWnBLTlhtX05faXdwNGZTOVNMV1BzT0ktczNVcXllRnRQU0F2WExvR1hMSkE4Q3J5aVNTc25LOFdQUDVDQW5xOWdudmFIRjFEMU9xckZaUHVCaFNCY1loZDJXYkVrRm5UaGV1QUxuTkd6cXVOTkp3MmhNLXAwODJBZ19EdzlYWWFMdGtMc2k2TFZLUERiWjViSUZ4cExqZw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cancer CAR-T developer Caribou has $142.8M to fund trials into 2H 2027", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxORUl2aTlLVndZelIzaGVMZTJLQjhtamhKcUIxUkNCcjRudk84aTVFbDNKTXpudFZvYlY3dU4xc0huYTBFOEpWMjc2WWgxNmsxeWZzaTh1dk5iVFZlUWpoNUhobVg2RU04RjlHbldTMjdIeWFtMmRrX3VvYzBvZng3SEJHbGVOLXlZVTN6dTRqUDVwanJhS2kzSjk1MUJJamhpblE3UDMxMHhXVVRia04xTnRQS1pGdVE?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences (CRBU)\u2019s CB-011 May Reach $734 Million in Peak 2040 Sales, According to Clear Street", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxNVjRkYkJkWG52aldBN29FQTRhSlBoVFJOVkQ0Q3hiRldXZGlQa1V2NXQ2bGtxMk9yT2RUNTNFTjVwalBzdWtWXzdRNHJSQnY5SWhvSXpQbXFzTXJLTXpZLTlreTlQLXRwVGpKUlQxQms3bWhucG4tSUpaYmkxTjVhcUZsRQ?oc=5", "source_name": "Market source", "published_at": "2026-02-20T08:00:00+00:00", "published_display": "20 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences (CRBU) Upgraded to Buy: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQZl9OeExfLUVwcDZJaWxjbDdaVWxUd0Z1VFVpZUNhWlZNT1dDa05kd1NqUmhqV2dDRWVaU1RlYlo3bUFBY09CdERGRUVoYUU4N081ZDZWczFmcVRjbC14Z3lXZmlGTnZtaXJxanRxQW84MjFpclBNRDlHNGNpQmk1Q0FOcXJzcUFrTXB3?oc=5", "source_name": "Market source", "published_at": "2026-01-13T08:00:00+00:00", "published_display": "13 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences Stock Soars Pre-market On Positive Early Trial Data For Cancer Treatments", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxOeDMxd1JXdkt6c2FUeXFBVVo3R09RNEtxRE0tQm94LS10WGYxQVdQb05XUWszaGIwV1RqZTlqcU5FU0VHbzFDVnB3ZTdFejNZWW9MZ1Jfc2RYZ0Vqd3BXZGJfbGg4cTFqYjg2d0JaUldUelB6TlllcHBaODZJRXNSMlF3LXNCUXBJLTJTYkJSYUFnUXphTlo0Vm4ySi13SWRBMjk2Zi1UWjB0ejUxMmdOdWdIcGctelpfaHcwTzdleW5xYjNZYjJ5YzVRSmZHMHVraEd1RmZCcjRqbVRVZUlRMzZxb0Fpb1RQbWtZbE5B?oc=5", "source_name": "Stocktwits", "published_at": "2025-11-03T13:03:47+00:00", "published_display": "03 Nov 2025 13:03", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Caribou Biosciences Inc (CRBU) Institutional Confidence", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE9PQ3NXRHBjLUF4OU9EbDFHMW1KVE1pYy0wS3ZiZjQ2MTgwcHhuM3pZWjVBdk9kamhMeVBNWXVVd0pCMkdQeXRtQWJrYmNOWmpkTkJ1Z2VwZEQ0OU41YTFCU0hwTHRLbjN2WHFTZE1tdTU?oc=5", "source_name": "TradingKey", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Medical Stocks Lagging Caribou Biosciences (CRBU) This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxONXJDUllyVkQ0RlBmRGhJVGtWWl9wbGZvRVhkV2RJbTRBN1l3M2hFNVhyamhhLW9KN1dFX0ktY2JlTzhHS1FOWkp3OUJCVDY2U0VoSU1uTEdlbTZZUnF0WWlsbzRzaUh6RENGMkNwa0dha1JJeENwb0xycEhzdWZ1eDBicDQ2WnBuTVF3ZFIzbnFQZkNGRGpOWElUZFl1RHNRbUc5Vy1R?oc=5", "source_name": "Market source", "published_at": "2026-07-09T13:40:04+00:00", "published_display": "09 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou CEO set for fireside chat at cell therapy conference June 30", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPQ1djN1NnVTkwZUhvSW5rbWhNQkd6ZzQ5VHNvSEwxUDNDZnZZZzhzYXlzYWlhQ1dKWG9WTkpxM1JkVVdFdUE2Q1JTY1ZtbmVGZFFXbnllbjBQUDJpejBRSk1DOExDaHJKdjRwNkh0OWRfdHhyaGktVGNEQjNJTWFXcWw0aGtiaDFQRng5N0piMFBkMlpOZ3l2TGstOEtIU2s2WUhEYVVycDN3OXh5YUk1NGNwYXpId0hCM3FZSzhCMA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-29T12:05:19+00:00", "published_display": "29 Jun 2026 12:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/caribou-biosciences-participate-h-c-120000570.html", "source_name": "GlobeNewswire", "published_at": "2026-06-29T12:00:00+00:00", "published_display": "29 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences (NASDAQ: CRBU) holders reject officer exculpation", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPSUlNdkZ0QjFHQ2F1RDBoak03VlFqVnVTWUdVZkgzNHhaYU5lRks3WnNDUzVVd1k3bGZ5dHA0eHMtb2M0NEFaSUFIb1N0eG5wQXB0dTVGVEZNZUNfdFYtV2hpS3dwdmZ5RnowRnZhX085MENsX3FPWjlpbzJlZEV2eEE5UjYxZy1oSDRrZVQwMmdvMUdRM2M4NlBodTZEVm1xZGx0ckNWalMxNmVXaFFpT3dR?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CRBU News | CARIBOU BIOSCIENCES INC (NASDAQ:CRBU)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE9PODAzUVczQUItUW1RRDBaMGtBeDJIcmFTLVFrSFJNeUZBX2NEZndnSDNLbTVDX3Bidy03ZnJSSVcxWTVRMktCRGlrdGZlWkpLVllSSkM2OGZmQXM?oc=5", "source_name": "ChartMill", "published_at": "2026-06-17T00:00:00+00:00", "published_display": "17 Jun 2026 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQSHBsb1daN1ZUbkdTTF91b0pNVkxpdUVxcXVGWHc4WjVwc3FmWXo3S0haVEp5eUhhd0YyazJ5Mk8xUFJCd0I0cVBKUW4xODlYMnVIUzVmbGdadnZkbVJKLXItM09hbWtGbHhFd0ItQ2JQMHM2elE4TE90NDVPRTR6QW9HMGc3MWkycmo4OUR4cGxxZmNBQ1FTYmlvTHNabmoxSjBRWkFJbDEycnJ6T2c0dU9rWGd0S095b3ZnYW5YVExoZHJfS0pR?oc=5", "source_name": "Investing News Network", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences, Inc. (CRBU) Presents at European Hematology Association (EHA) 2026 Congress - Slideshow", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPemFQMFpDUXJGT3JpS0ZqTXNTMTNwQWlsaUxiZVBXdUtBNERnWTdzLXFkN05BRTVGUFN2STJzclYzd3diYjM0T3ZILWthbE50NFo0LUljQWd1X2NNSENKUU9lZlQyNGQtRVY0NG16YzdGZVFJUnN3NndFeXVEUFFFWEJ3UkNBUmsteHJGR2V5SmQ2YmhJNjF2a053VkMzel9BdURiY2xkRGtzX0hqUU1tWjdwZXZJLUZDTXB2bkY3dVNtRlRXVmVYaXA3RQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences Potential Non-Hodgkin Lymphoma Cell Therapy Shows 'Durable' Responses", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/caribou-biosciences-potential-non-hodgkin-124018133.html", "source_name": "MT Newswires", "published_at": "2026-06-11T12:40:18+00:00", "published_display": "11 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/caribou-biosciences-reports-dose-escalation-120000206.html", "source_name": "GlobeNewswire", "published_at": "2026-06-11T12:00:00+00:00", "published_display": "11 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences (CRBU) reports durable phase 1 CAR-T responses in lymphoma and myeloma", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPM1dlcU1QMVlfOHp1UVpwYzZHM3pna2czRm5LbUUxQnVBTjdOV0hyY19JejRUcnZSTjd5TUp5aWdScWpvQjB5NkJlemIxV21ZTG1pQ2pGWjBhTVcwVFZ5ZDd2RndzOXZrOTJTcjd1YXJUaXJ5VWJ4TjdQTTd0cUtkMmlFMHVXcTl1WVpzMkgxeGUyRHczTjJwNDdmaU9WYVNGbzBBMlBodWpRbTAwNm92MlRB?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences Says CRISPR CAR-T Is Pivotal-Ready, CB-011 Data Nears", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOS1ZtWDdRQmZ3XzJ0MllueHpSTm5GU290ODBHTE90RkxTR0hRLW0tbEFnNWJoTENhQ1g5blhuUV92VWxRWTQ4UHFuV1FST25OSDBBaGhraGZSV1loSDB1QVNjNkZha05QRm9WMG1zNWc0LWJDazBwN05Vb2F5WE8wYlFqTUhaVHBGV1pJbWpMY3IwYTJkUl9JY3BrcVk2OVhGdXhrWHg1Yw?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences (CRBU) Gets A Higher Target As Confidence In Its Pipeline Grows", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOX2NDNnlNT1RPV2gxWGs5X1N3c1pFblI3Y3J4eUEtOWNOdG9TajFwd1p5X2Y0THBzdDRRVkgxdlRvV05SLWZiQjZ3T1FjNXVCTUhCY2x2QjNUSy13QTQ4YU9IMElzNGthb3VJUFBzWERJNmJndU5jazVRYmVaQWVtbjhyS0VNcmxHX1Rta3o3VmZHR0ZjRlFtQlEzTHNpbThyNUhtQ1Q4eEM?oc=5", "source_name": "Market source", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/caribou-biosciences-participate-2026-jefferies-200500567.html", "source_name": "GlobeNewswire", "published_at": "2026-05-27T20:05:00+00:00", "published_display": "27 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou CEO in Jefferies 2026 healthcare fireside chat", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPQnNxTldEdnYwVkNSX2lKV1lFd2E4b2wzOGxPbXNlZmo5bVBRVzRMSnN1bDg4MTdXT0JTaVdLT1IwRmFXSm5qTFdjUURXY1ZBN0hxYUM5VzFYTzB2RG1nT1hrLUNmYlN4X1Q5R0sxRUpiNm9HekR3SzRBaGE5S2VweDh2d1ZmUlVJbVk0eG1pbGw0RU5SQS1EZG4zYUwwZnF3ZXdxUUVwOThvbGdaYTlKaExpWU9IZWVINUE?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference", "summary": "", "url": "https://finance.yahoo.com/news/caribou-biosciences-participate-h-c-200500953.html", "source_name": "GlobeNewswire", "published_at": "2026-05-13T20:05:00+00:00", "published_display": "13 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Need To Know: Analysts Are Much More Bullish On Caribou Biosciences, Inc. (NASDAQ:CRBU) Revenues", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Industry Analysts Just Made A Massive Upgrade To Their Caribou Biosciences, Inc. (NASDAQ:CRBU) Revenue Forecasts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNd3M4WkVVSEV3SDRhVVpxUVUxQ050OEhzQ2pIdHR6a05vVzVFeHRHOFJVVm5PY2tnZUNQN1VnV2hzVUppNnE1ckp2TjZEVXRhblpnTExWdjYtZjZ5ek9MZFlYOVh0SG9QVFNfSDU1bkdwbkpvZ2cxN1c3cGhuR05ZbUx3MmNvZ0JX?oc=5", "source_name": "Market source", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CRISPR biotech Caribou Biosciences plans H.C. Wainwright talk May 19", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQeDRPWkZMQUZ3anRfcUI3VzE5V2tzQkxhejFfVFZWbDlTZ1RiVG44YVdlQmxyZnE5SDJ4a1FhY2Q4amticmVPeHVac183aUF4bEVtMFU2M0tOS0RBRjhtbW40bzlLcm55UUFWdFhLMDNPdEVpN0gxTHVzZklsbjZ3Y1YzSS1HdWdtNEd0Xy12eC1ReVRVaDl0VG5mQ1RreDd0eGItbjBnR2Zad0VBUGphWElJT25vNHNaalViOThITQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNcVYxOUVZcTc5eXpfV05yRG9tdEQ1aktjZ2stNm1QMDNiSnd3Uk52cEQ4QzQxMFdvUGhnRDJEdkVDemdhd0FPdVZ1M1V4WWNKWHU1ZEZRVFlkZXIzRWZ4SUVYM1hJTUZRMU8tSGlESjBpUzdiN09rcEdKMjY0NVZ1VE83NXY1cjdFOUtMVk9VTkZnR1Z5RmVWVUg2TjhXR1NidVJKcGtYUUw?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences to Participate in the BofA Securities 2026 Health Care Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPLVNwUHF0X0Q4cGJzaVp2T1YyV3ZhVl9CN2toeUtnX3BSQjVYdnZOaTItUWVTTFY5Z3BRRk5qMXZweDE5Tjd5OHJnU3lfYUlDZmdPZk1QZUluUnRQQmV3NG04WFFhUEJaNlpCY09ESk16Uy01MmtPLVExdXRRZXFDLWdiWFhYeXliVWd6X3pNaWxNdkR4R2N4S1c4RlV3M0hEUHJJbm9oWHg2TjVzd21zdWhR?oc=5", "source_name": "Investing News Network", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOZEtreE5mUkxCdXhVa3NCVjNfR0xQWnBLTlhtX05faXdwNGZTOVNMV1BzT0ktczNVcXllRnRQU0F2WExvR1hMSkE4Q3J5aVNTc25LOFdQUDVDQW5xOWdudmFIRjFEMU9xckZaUHVCaFNCY1loZDJXYkVrRm5UaGV1QUxuTkd6cXVOTkp3MmhNLXAwODJBZ19EdzlYWWFMdGtMc2k2TFZLUERiWjViSUZ4cExqZw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cancer CAR-T developer Caribou has $142.8M to fund trials into 2H 2027", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxORUl2aTlLVndZelIzaGVMZTJLQjhtamhKcUIxUkNCcjRudk84aTVFbDNKTXpudFZvYlY3dU4xc0huYTBFOEpWMjc2WWgxNmsxeWZzaTh1dk5iVFZlUWpoNUhobVg2RU04RjlHbldTMjdIeWFtMmRrX3VvYzBvZng3SEJHbGVOLXlZVTN6dTRqUDVwanJhS2kzSjk1MUJJamhpblE3UDMxMHhXVVRia04xTnRQS1pGdVE?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences (CRBU)\u2019s CB-011 May Reach $734 Million in Peak 2040 Sales, According to Clear Street", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxNVjRkYkJkWG52aldBN29FQTRhSlBoVFJOVkQ0Q3hiRldXZGlQa1V2NXQ2bGtxMk9yT2RUNTNFTjVwalBzdWtWXzdRNHJSQnY5SWhvSXpQbXFzTXJLTXpZLTlreTlQLXRwVGpKUlQxQms3bWhucG4tSUpaYmkxTjVhcUZsRQ?oc=5", "source_name": "Market source", "published_at": "2026-02-20T08:00:00+00:00", "published_display": "20 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences (CRBU) Upgraded to Buy: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQZl9OeExfLUVwcDZJaWxjbDdaVWxUd0Z1VFVpZUNhWlZNT1dDa05kd1NqUmhqV2dDRWVaU1RlYlo3bUFBY09CdERGRUVoYUU4N081ZDZWczFmcVRjbC14Z3lXZmlGTnZtaXJxanRxQW84MjFpclBNRDlHNGNpQmk1Q0FOcXJzcUFrTXB3?oc=5", "source_name": "Market source", "published_at": "2026-01-13T08:00:00+00:00", "published_display": "13 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caribou Biosciences Stock Soars Pre-market On Positive Early Trial Data For Cancer Treatments", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxOeDMxd1JXdkt6c2FUeXFBVVo3R09RNEtxRE0tQm94LS10WGYxQVdQb05XUWszaGIwV1RqZTlqcU5FU0VHbzFDVnB3ZTdFejNZWW9MZ1Jfc2RYZ0Vqd3BXZGJfbGg4cTFqYjg2d0JaUldUelB6TlllcHBaODZJRXNSMlF3LXNCUXBJLTJTYkJSYUFnUXphTlo0Vm4ySi13SWRBMjk2Zi1UWjB0ejUxMmdOdWdIcGctelpfaHcwTzdleW5xYjNZYjJ5YzVRSmZHMHVraEd1RmZCcjRqbVRVZUlRMzZxb0Fpb1RQbWtZbE5B?oc=5", "source_name": "Stocktwits", "published_at": "2025-11-03T13:03:47+00:00", "published_display": "03 Nov 2025 13:03", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 77, "total_relevant": 34, "sentiment_summary": {"positive": 6, "negative": 2, "neutral": 26, "score": 52, "total": 34, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 11.9, "count": 21}, {"event": "earnings", "label": "Earnings", "weight": 4.4, "count": 10}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.9, "count": 1}], "positive_events": 6, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 1.93, "latest_week": "2026-07-10", "one_week_move": 5.8, "four_week_move": 20.7, "twelve_week_move": -12.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.455222, "market_dynamics_buy_signal": false, "relative_strength": -13.88676, "fair_value_gap": -31.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 46.8039, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+5.8% over one week, +20.7% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 12}, {"label": "Stock Titan", "count": 6}, {"label": "GlobeNewswire", "count": 4}, {"label": "simplywall.st", "count": 3}, {"label": "Investing News Network", "count": 2}, {"label": "Seeking Alpha", "count": 2}, {"label": "TradingKey", "count": 1}, {"label": "ChartMill", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 26}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 21}, {"label": "Earnings", "count": 10}, {"label": "Analyst action", "count": 2}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "26", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+5.8% over one week, +20.7% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Caribou Biosciences Inc (CRBU) Institutional Confidence"}], "updated_at": "2026-07-16T02:16:27.769838+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}